Crosstalk between TGF-β and VEGF/PLGF signaling has been demonstrated to exhibit both pro- and anti-angiogenic actions in human brain-derived microvascular endothelial cells (hCMECs) and glioblastoma-derived endothelial cells (GMECs). This evidence concerns the gene TGFB1 and glioblastoma.